
|Articles|May 12, 2008
Cimzia approved for signs and symptoms of Crohn's disease
UCB receives FDA approval for certolizumab pegol (Cimzia).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Long-Term Adverse Effects After COVID-19 Vaccination Vary by Brand
2
Individualized Approach Helps When Intensifying GLP-1 Therapy in T2D
3
Meta-Analysis Identifies 5 Risk Factors for Post-COVID-19 Condition
4
Model Finds Weight Regain After Stopping Semaglutide or Tirzepatide
5







































